Serum level of vascular endothelial growth factor in children with acute leukemia
GAI Zhi-Min, ZHANG Su-Gui, MA Xiao-Hong
Abstract No abstract available
Cite this article:
GAI Zhi-Min,ZHANG Su-Gui,MA Xiao-Hong. Serum level of vascular endothelial growth factor in children with acute leukemia[J]. 中国当代儿科杂志, 2003, 5(4): 351-352.
GAI Zhi-Min,ZHANG Su-Gui,MA Xiao-Hong. Serum level of vascular endothelial growth factor in children with acute leukemia[J]. CJCP, 2003, 5(4): 351-352.
URL:
http://www.zgddek.com/EN/ OR http://www.zgddek.com/EN/Y2003/V5/I4/351
[1]
WU Yuan-Yuan, CAI Sheng-Yang, HUANG Wei, LI Si-Si, LI Wei, DONG Ao. Clinical and laboratory characteristics of juvenile myelomonocytic leukemia [J]. CJCP, 2018, 20(5): 373-377.
[2]
CHENG Yan-Qin, ZHAI Xiao-Wen. Clinical application of minimal residual disease detection in childhood acute leukemia [J]. CJCP, 2018, 20(5): 416-420.
[3]
ZHANG Wan-Yan, ZHANG Yuan, DONG Nan-Nan, WANG Ying-Chao, SHENG Guang-Yao, XU Xue-Ju, LIU Yu-Feng. Clinical features and prognosis of malignancy-associated hemophagocytic lymphohistiocytosis in children: a clinical analysis of 24 cases [J]. CJCP, 2018, 20(4): 295-297.
[4]
CHEN Xiao-Xiao, SHEN Shu-Hong. Research advances in pharmacogenomics of mercaptopurine [J]. CJCP, 2017, 19(9): 1027-1033.
[5]
XU Jin-Yun, LUO Jian-Ming. Association between BIM gene and glucocorticoid resistance in children with acute lymphoblastic leukemia [J]. CJCP, 2017, 19(8): 945-948.
[6]
FU Xiao-Yan, XIE Xiao-Tian, ZHAO Yan. Neurocognitive function of children with acute lymphoblastic leukemia and long-term disease-free survival and related influencing factors [J]. CJCP, 2017, 19(8): 899-903.
[7]
WANG Ni-Na, YE Qi-Dong. Advances in targeted therapy for childhood acute myeloid leukemia [J]. CJCP, 2017, 19(7): 832-836.
[8]
WU Jun, LU Ai-Dong, ZHANG Le-Ping. Clinical characteristics and prognostic analysis of children and adolescents over 10 years of age with acute lymphoblastic leukemia [J]. CJCP, 2017, 19(6): 614-619.
[9]
KONG Qing-Lin, AN Xi-Zhou, GUAN Xian-Min, MA Yi-Mei, LI Peng-Fei, LIANG Shao-Yan, HU Yan-Ni, CUI Ying-Hui, YU Jie. Expression of β-integrin family members in children with T-cell acute lymphoblastic leukemia [J]. CJCP, 2017, 19(6): 620-626.
[10]
CHEN Zai-Sheng, ZHENG Ling, CHEN Yi-Qiao, YANG Jing-Hui, LI Jian. Pathogens of infections in the induction period of childhood acute lymphoblastic leukemia and drug resistance of isolated strains [J]. CJCP, 2017, 19(2): 176-181.
[11]
ZHANG Pei-Fen, FENG Xiao-Qin, WU Cui-Ling, ZHANG Yu-Ming. Clinical features of children with acute lymphoblastic leukemia complicated by pulmonary infection after chemotherapy [J]. CJCP, 2017, 19(12): 1234-1238.
[12]
NI Ya-Ru, XU Xiao-Jun, TANG Yong-Min. Progress in clinical studies of chimeric antigen receptor engineered T cells for treatment of childhood cancer [J]. CJCP, 2017, 19(11): 1219-1224.
[13]
MU Qing-Jie, ZHAO Yue-Hua, CHENG Dan-Dan, WANG Hai-Yu, CHEN Lan-Fen, ZHAO Yan-Song, WANG Xiao-Li. Effects of bone marrow mesenchymal stem cell transplantation on retinal neovascularization in neonatal rats with oxygen-induced retinopathy [J]. CJCP, 2017, 19(11): 1202-1207.
[14]
TANG Xue, GUO Xia. Research progress in Ph-like childhood acute lymphoblastic leukemia [J]. CJCP, 2017, 19(11): 1213-1218.
[15]
YE Zhen-Zhen, XUE Fei-Long, DING Wen-Ping, KONG Xiang, SHEN Yi-Na. Oridonin inhibits proliferation of Jurkat cells via the down-regulation of Brg1 [J]. CJCP, 2017, 19(11): 1208-1212.